No insider purchase over the last 90 days. The latest, by ANDREEFF DANE, was filed 19 May 2020.
Helius Medical Technologies, Inc. is a listed company. Its directors and officers file their transactions with SEDI. The past year has been quiet: not a single insider filing for Helius Medical Technologies, Inc. The previous disclosure was published on 26 October 2020.
Over the whole record (from 2016), the tally stands at 36 purchases and no sales.
Source: insider filings from SEDI. Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 79 declarations
Helius Medical Technologies, Inc. is a company focused on developing medical technologies for the treatment of neurological disorders. It is listed on the Toronto Stock Exchange under the symbol XTSE.